Literature DB >> 8564125

Early detection of lung involvement in lysinuric protein intolerance: role of high-resolution computed tomography and radioisotopic methods.

F Santamaria1, G Parenti, G Guidi, A Rotondo, G Grillo, M R Larocca, L Celentano, P Strisciuglio, G Sebastio, G Andria.   

Abstract

Pulmonary disease of unknown etiology is a potentially fatal complication in patients with lysinuric protein intolerance (LPI), an autosomal recessive disorder caused by the defective transport of cationic amino acids. Lung involvement was investigated in nine Italian LPI patients through pulmonary function tests and lung imaging studies consisting of conventional chest radiography, high-resolution computed tomography (HRCT), and perfusion and ventilation scintigraphy. One 10-yr-old patient died of severe respiratory insufficiency from alveolar proteinosis. All of the remaining patients were asymptomatic at the time of the study, although HRCT scans revealed signs of lung involvement defined by the presence of acinar nodules, inter- and/or intralobular thickening of the interstitial septa, and subpleural cysts in five of the patients. Radioisotope studies showed an uneven distribution of perfusion and ventilation, and confirmed the presence of segmental and/or diffuse pulmonary functional defects. No abnormalities of pulmonary function were evident, and answers to a questionnaire excluded primary coexisting lung disease. In patients with LPI, including those without clinical and functional impairment, HRCT and radioisotopic studies appear to be the most sensitive methods for the early diagnosis of lung disease and correct assessment of its progression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564125     DOI: 10.1164/ajrccm.153.2.8564125

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Lung involvement in children with lysinuric protein intolerance.

Authors:  Sarah Valimahamed-Mitha; Laureline Berteloot; Héloise Ducoin; Chris Ottolenghi; Pascale de Lonlay; Jacques de Blic
Journal:  J Inherit Metab Dis       Date:  2014-10-22       Impact factor: 4.982

2.  Inhaled Sargramostim Induces Resolution of Pulmonary Alveolar Proteinosis in Lysinuric Protein Intolerance.

Authors:  Laura M Tanner; Johanna Kurko; Maaria Tringham; Heikki Aho; Juha Mykkänen; Kirsti Näntö-Salonen; Harri Niinikoski; Heikki Lukkarinen
Journal:  JIMD Rep       Date:  2016-10-26

Review 3.  Overview of symptoms and treatment for lysinuric protein intolerance.

Authors:  Atsuko Noguchi; Tsutomu Takahashi
Journal:  J Hum Genet       Date:  2019-06-18       Impact factor: 3.172

Review 4.  Interstitial lung disease in infants: new classification system, imaging technique, clinical presentation and imaging findings.

Authors:  Edward Y Lee
Journal:  Pediatr Radiol       Date:  2012-11-15

5.  First reported case of lysinuric protein intolerance (LPI) in Lithuania, confirmed biochemically and by DNA analysis.

Authors:  Loreta Cimbalistiene; Willy Lehnert; Kirsi Huoponen; Vaidutis Kucinskas
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

6.  Imaging of Childhood Interstitial Lung Disease.

Authors:  R Paul Guillerman
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 7.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

8.  Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.

Authors:  M P Sperandeo; M T Bassi; M Riboni; G Parenti; A Buoninconti; M Manzoni; B Incerti; M R Larocca; M Di Rocco; P Strisciuglio; I Dianzani; R Parini; M Candito; F Endo; A Ballabio; G Andria; G Sebastio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

9.  In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages.

Authors:  Amelia Barilli; Bianca Maria Rotoli; Rossana Visigalli; Ovidio Bussolati; Gian C Gazzola; Zamir Kadija; Giuseppe Rodi; Francesca Mariani; Maria Lorena Ruzza; Maurizio Luisetti; Valeria Dall'Asta
Journal:  Orphanet J Rare Dis       Date:  2010-11-26       Impact factor: 4.123

10.  Hypertransaminasemia and fatal lung disease: a case report.

Authors:  Francesca Santamaria; Sara De Stefano; Silvia Montella; Marco Maglione; Roberto Della Casa; Emma Acampora; Claudio Pignata; Mariacarolina Salerno; Giancarlo Parenti
Journal:  Ital J Pediatr       Date:  2013-02-07       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.